Find a study
Match me to a study95 studies
Recruiting now, in plain language. Every study is watched over by an independent ethics board.
- Obesity / overweightHeart / cardiovascular disease
π Advanced Cardiovascular, LLC Β· Alexander City, AL Β· +39 more US sites Β· Get directions β
This study is being done to look at the safety and effect of NNC0487-0111 in people with Heart Failure with preserved Ejection Fraction (HFpEF) or Heart Failure with mildly reduced Ejection Fraction (HFmrEF) and excess body weight when compared to placebo. The purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have HFpEF or HFmrEF and excess body weight.
- Obesity / overweightHeart / cardiovascular disease
π Alliance For Multispecialty Research - Daphne Β· Daphne, AL Β· +39 more US sites Β· Get directions β
The primary objective of this trial is to demonstrate that maridebart cafraglutide is superior to placebo when given as an adjunct to standard of care with respect to reducing cardiovascular (CV) morbidity and mortality.
- Obesity / overweightHeart / cardiovascular disease
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
π΅ May compensateπ University of Alabama Saint Vincent's Birmingham Β· Birmingham, AL Β· +39 more US sites Β· Get directions β
This trial will examine if maridebart cafraglutide as an adjunct to standard of care will lead to a reduction in heart failure (HF) events such as HF hospitalizations and urgent HF visits, cardiovascular (CV) deaths and improvement in HF symptoms in participants with HF with preserved ejection fraction (HFpEF) and HF with mildly reduced ejection fraction (HFmrEF) who are obese. This is a phase 3, global, multicenter, 2-part trial with a double-blind period and an open-label extension (OLE).
- Heart / cardiovascular diseaseHigh blood pressure
π Pinnacle Research Group, LLC Β· Anniston, AL Β· +39 more US sites Β· Get directions β
This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure.
- Type 2 diabetesHeart / cardiovascular diseaseHigh blood pressure
π Research Site Β· Fortaleza, CearΓ‘ Β· Get directions β
To provide real world data on patient characteristics, disease management, healthcare utilization, and outcomes in patients with type 2 diabetes, Hypertension, Heart failure and/or Chronic kidney diseases
- Heart / cardiovascular disease
π Nephrology of North Alabama Β· Decatur, AL Β· +39 more US sites Β· Get directions β
This is a two-part, phase 2b and phase 3 combined prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1: Phase 2b is a dose-finding study for CSL300 vs placebo.
- Heart / cardiovascular diseaseKidney disease
π Instituto de Investigaciones ClΓnicas Bahia Blanca Β· BahΓa Blanca, Β· Get directions β
The purpose of this study is to measure cardiovascular outcomes with orforglipron compared with placebo in participants with atherosclerotic cardiovascular disease (ASCVD) and/or chronic kidney disease (CKD). Participation in the study will last about 5 years.
- Heart / cardiovascular diseaseHigh blood pressureKidney disease
π Phoenix Children's Hospital Β· Phoenix, AZ Β· +39 more US sites Β· Get directions β
The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to evaluate the PK of understudied drugs currently being administered to children per SOC as prescribed by their treating provider.
β Study care freeLearn more β - Heart / cardiovascular disease
π Curtin University Β· Bentley, Western Australia Β· Get directions β
To evaluate the efficacy and safety of colchicine and non-enteric coated aspirin, combined or alone, to improve cardiovascular outcomes in high-risk patients with type 2 diabetes.
- Heart / cardiovascular diseaseKidney disease
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
π΅ May compensateπ Stanford University Medical Center Β· Stanford, CA Β· +12 more US sites Β· Get directions β
Powerful new drugs that can prevent or delay end stage kidney disease (ESKD) - so called sodium-glucose cotransporter-2 inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 diabetes (T1D) remains unknown because of the few studies in this population, due to concerns about the increase in risk of diabetic ketoacidosis (DKA, a serious, potentially fatal acute complication of diabetes due to the accumulation of substances called ketone bodies) observed with SGLT2i therapy in T1D.
- Type 2 diabetesHeart / cardiovascular disease
π Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center (The Lundquist Institute) Β· Torrance, CA Β· Get directions β
A multi-center, randomized, double-blind, placebo-controlled, parallel-group phase IV Study evaluating the effects of tirzepatide on atherosclerotic plaque progression assessed by coronary computed tomography angiography (CCTA) in participants with a diagnosis of type II Diabetes (T2DM) and atherosclerosis.
- Heart / cardiovascular diseaseHigh blood pressureKidney disease
π Stanford Hospital and Clinics Β· Stanford, CA Β· +11 more US sites Β· Get directions β
The purpose of the SPYRAL GEMINI Pilot Study is to evaluate that multi-organ denervation with the Gemini System is safe and provide evidence of blood pressure reduction when studied in an uncontrolled hypertensive population with and without high cardiovascular risk.
- Obesity / overweightHeart / cardiovascular disease
π Site 108 Β· Chandler, AZ Β· +11 more US sites Β· Get directions β
The purpose of this study is to learn about the effects of BGE-102 on blood biomarkers including hsCRP, which is a lab value used to measure inflammation. BGE-102 decreases inflammation which may improve obesity and cardiovascular health.
- Heart / cardiovascular diseaseDepressionAnxiety
π Seaway Valley Community Health Centre (Cardiac Rehab Program) Β· Cornwall, Ontario Β· Get directions β
Heart failure is a high-risk, chronic condition that impacts patients' mental health. Approximately 50% of heart failure patients experience comorbid mental health conditions, such as stress, depression and anxiety, which affect their day-to-day lives.
- Heart / cardiovascular disease
π Markham HealthPlex Medical Centre Β· Markham, Ontario Β· Get directions β
ORIGINS-VRCE-2 is an observational study aimed to assess how blood vessel forming stem cells from individuals without diabetes or a history of cardiovascular disease differ between individuals of South Asian and European ethnicities. The overarching objective of the study is to investigate whether differential vessel reparative stem cell populations and characteristics may underlie the elevated cardiovascular risk observed among South Asian individuals compared to individuals of European origins.
- Heart / cardiovascular diseaseKidney disease
π Fountains Family Care Β· Chandler, AZ Β· +3 more US sites Β· Get directions β
The primary objective of CHAPERONE solution is to evaluate the efficacy of engaging, assessing, and enabling long term treatment strategy with Health Artificial Intelligence (AI) Chatbot, Copilot, Large Language Model (LLM) and vital sign monitoring device in reducing CKM disease burden using an algorithm obtained from biomarkers and diagnostics utilizing remote sensor driven technology tools, care coordination and patient empowerment.
- Heart / cardiovascular diseaseKidney disease
π UPMC Kidney Clinic - Wexford Β· Pittsburgh, PA Β· +4 more US sites Β· Get directions β
Purpose of the Study: This clinical trial will test whether a nutrition and kidney health program can work well for adults with kidney disease. The program was created with help from patients and community partners.
- Type 2 diabetesHeart / cardiovascular diseaseKidney disease
π Ohio State Healthy Community Center Β· Columbus, OH Β· +3 more US sites Β· Get directions β
Food and Fitness with Medicine (FFWM) is a 24-week randomized controlled trial (RCT) enrolling 200 post-menopausal women (PMW) with stage 2 cardio-kidney metabolic (CKM) syndrome and type-2 diabetes (T2D) within 6 weeks of initiating glucagon-like peptide-1 receptor agonist (GLP-1RAs) to: 1. Examine discontinuation rates of GLP-1RAs (primary outcome); 2.
- Heart / cardiovascular disease
π Healthcare Integrated Research Database (HIRD) Β· Wilmington, DE Β· Get directions β
The aim of this study is to evaluate the risk of serious adverse cardiovascular events in adolescent and adult patients with severe asthma taking tezepelumab compared to a population receiving standard of care treatment for severe asthma.
- Heart / cardiovascular disease
π VA Clinic - Gainesville Β· Gainesville, FL Β· +3 more US sites Β· Get directions β
This study will test the effectiveness of a culturally-sensitive, telephone-based, tailored problem-solving intervention to improve physical and mental health in Veterans with heart failure (HF). Veterans will be recruited from VA clinics throughout the United States.
- Obesity / overweightHeart / cardiovascular disease
π Hope Center Β· Washington D.C., DC Β· +2 more US sites Β· Get directions β
Background: \- Researchers are interested in studying individuals who have known or suspected metabolic, inflammatory or genetic diseases that may put them at a high risk for heart diseases or diseases of their blood vessels. Depending on the condition being studied, both affected and nonaffected individuals may be asked to provide blood and other samples and may undergo tests to evaluate the heart, blood vessels and lung function.
- Obesity / overweightHeart / cardiovascular diseaseHigh blood pressure
π UConn Health Β· Farmington, CT Β· +2 more US sites Β· Get directions β
The investigators will conduct a feasibility and pilot efficacy randomized controlled trial to test the usability and user satisfaction of an evidence-based digital health tool the investigators developed for physicians to use to Prioritize Personalize Prescribe EXercise (P3-EX) to patients with cardiovascular disease (CVD) risk factors. The investigators will recruit 24 physicians from two local hospitals in CT, USA.
- Type 2 diabetesHeart / cardiovascular diseaseHigh blood pressure
π Fort Campbell Β· Fort Campbell, KY Β· +2 more US sites Β· Get directions β
The Military Health and Nutrition Examination Study (MHANES) is a Department of Defense funded study conducted by Pennington Biomedical Research Center and the US Army Research Institute of Environmental Medicine. This cross-sectional study will assess, in a large, diverse sample of Army Service Members (n=600), food and supplement intake, cardiovascular health, body composition, biomarkers of nutritional status, measures of health status, injury prevalence, mental wellbeing, gut microbiome composition, and physical performance outcomes.
- Heart / cardiovascular diseaseKidney disease
π NIDDK-Phoenix Epidemiology and Clinical Research Β· Phoenix, AZ Β· +2 more US sites Β· Get directions β
Despite many advances in our understanding of the natural history and progression of chronic kidney disease (CKD) and cardio vascular disease (CVD) in the parent CRIC study over the past 15 years, important questions about key risk factors for these diseases remain unanswered in the AI population. To address this burden of CKD in AI communities Investigators formed a consortium of investigators with extensive experience in conducting research of chronic diseases including diabetes, cardiovascular and kidney disease in AIs of Southwestern US.
- Obesity / overweightHeart / cardiovascular disease
π Greenstone Biosciences Β· Palo Alto, CA Β· +1 more US site Β· Get directions β
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, primarily used for treatment of type-2 diabetes mellitus. GLP-1 receptors are present on pancreatic islet Ξ²-cells, Ξ΄-cells and Ξ±-cells.
- Obesity / overweightHeart / cardiovascular disease
π Johns Hopkins Center for Health Equity Β· Baltimore, MD Β· +1 more US site Β· Get directions β
This study aims to determine whether a 6-month multilevel intervention involving problem-solving training, exercise training and support from community health workers is more effective in improving outcomes for individuals with low socioeconomic status, type 2 diabetes, obesity, and early cardiac dysfunction than receiving education and access to a community exercise facility.
- Heart / cardiovascular disease
π CHUM Β· Montreal, Quebec Β· Get directions β
The goal of this pragmatic trial is to provide Real World Evidence (RWE) on the impact of the result of a polygenic risk prediction test of cardiorenal complications of T2D, so that more patients at high risk of these complications achieve over an 18 months period, recommended therapeutic targets. This will be demonstrated as a significant improvement in a composite value including HbA1c or systolic blood pressure (SBP) or albuminuria (UACR), or glomerular filtration rate (GFR) lowering.
- Type 2 diabetesHeart / cardiovascular disease
π North York Diagnostic and Cardiac Centre Β· North York, Ontario Β· Get directions β
PAD-VRCE is an observational, cross-sectional, two arm study aimed at determining if the presence of peripheral artery disease (PAD) can influence the number of circulating regenerative cells in blood. From peripheral blood samples, circulating progenitor cell content will be assessed via flow cytometry and compared between individuals with PAD and individuals without PAD.
- Heart / cardiovascular diseaseHigh blood pressureHigh cholesterol
π University of Tennessee Medical Center Β· Knoxville, TN Β· +1 more US site Β· Get directions β
Socioeconomically disadvantaged populations with multiple chronic conditions have high rates of nonadherence to essential chronic disease medications after hospital discharge. Medication nonadherence after hospital discharge is significantly associated with increased mortality and higher rates of readmissions and costs among these patients.
- Heart / cardiovascular diseaseKidney disease
π Foothills Medical Centre Β· Calgary, Alberta Β· Get directions β
Many people with kidney disease also have heart disease. The procedures used to diagnose and treat heart disease (e.g., angiograms, angioplasty, or surgery) can improve symptoms and cardiovascular outcomes, but pose greater risks of kidney complications for people with chronic kidney disease.
- Heart / cardiovascular diseaseKidney diseaseCOPD (chronic lung disease)
π Brigham and Women's Hospital Β· Boston, MA Β· +1 more US site Β· Get directions β
The investigators propose a home hospital model of care that substitutes for treatment in an acute care hospital. Limited studies of the home hospital model have demonstrated that a sizeable proportion of acute care can be delivered in the home with equal quality and safety, reduced cost, and improved patient experience.
- Heart / cardiovascular diseaseCOPD (chronic lung disease)
π VA Boston Β· Boston, MA Β· +1 more US site Β· Get directions β
The goal of this fully-remote randomized controlled trial is to test the efficacy of Mindful Steps in facilitating physical activity compared to usual standard of care among 136 patients with COPD and/or HF. The main question it aims to answer is can this intervention promote physical activity as measured by daily step counts in sedentary patients with COPD and/or HF.
- Heart / cardiovascular diseaseDepression
π Indiana University Β· Indianapolis, IN Β· +1 more US site Β· Get directions β
This observational study evaluates the accuracy of the Okaya AI platform in detecting fatigue and depression in cardiology patients, comparing its assessments to PHQ-9 and Fatigue Assessment Scale scores.
- Obesity / overweightHeart / cardiovascular diseaseHigh blood pressure
π University of Alabama at Birmingham Β· Birmingham, AL Β· Get directions β
The UAB Cardiovascular Research Biobank (CARBON) will be a resource that contains biological materials, such as DNA samples, in addition to health and personal information on a large number of people over time. It will be set up so that it can be used in the future as a resource for researchers undertaking a wide range of medical research.
- Obesity / overweightType 2 diabetesHeart / cardiovascular disease
π Vanderbilt_University MC Β· Nashville, TN Β· Get directions β
Metabolic surgery is an emerging option to treat obesity-related metabolic diseases (e.g., type 2 diabetes) and prevent cardiovascular disease (CVD). Metabolic surgery can profoundly alter the gut microbiota; meanwhile, gut microbiota may affect surgical outcomes.
- Obesity / overweightHeart / cardiovascular disease
π Arizona State University Β· Tempe, AZ Β· Get directions β
The purpose of this study is to determine the feasibility, acceptability, efficacy, and participant adherence in using home-based technologies and wearable devices and simple, practical strategies to reduce the negative impact that evening screen time may have on your health.
- Obesity / overweightHeart / cardiovascular disease
π Mayo Clinic in Rochester Β· Rochester, MN Β· Get directions β
The purpose of this study is to evaluate the impact of a cardiometabolic clinic on percent body weight loss, body mass index (BMI), and visceral adiposity distribution in obese adults with cardiovascular disease (CVD) at 12 months.
- Obesity / overweightHeart / cardiovascular disease
π University of Illinois at Chicago Β· Chicago, IL Β· Get directions β
The development of type II diabetes (T2D) is strongly associated with obesity and both are well-established risk factors for cardiovascular disease. Knowing that vascular dysfunction is an early event in the development of cardiovascular disease in obese diabetic (OB-T2D) patients, The investigators set their long-term goal to define molecular mechanisms of vascular dysfunction and corrective strategies that target these mechanisms such as physical activity and weight loss.
- Obesity / overweightHeart / cardiovascular diseaseHigh blood pressure
π Vanderbilt University Medical Center Β· Nashville, TN Β· Get directions β
The overall purpose of this study is to learn more about the metabolic effects of angiotensin-(1-7) in the insulin resistant state associated with obesity. Pharmacologic approaches to increase angiotensin-(1-7) levels or its actions are currently in development for treatment of metabolic-related diseases such as obesity and type II diabetes, based on findings from animal studies.
- Heart / cardiovascular disease
π University of California, Davis Β· Davis, CA Β· Get directions β
Recently a dietary recommendation of 400 - 600 mg/ day has been proposed for the reduced risk of developing cardiovascular disease. Dietary flavanols can be obtained from the intake of foods such as tea, cocoa, wine, berries and apples.
- Obesity / overweightHeart / cardiovascular disease
π Pennington Biomedical Research Center Β· Baton Rouge, LA Β· Get directions β
The goal of this study is to examine the impact of a diet high in fresh lean pork, compared to a plant-based diet, on cardiovascular function and vasomotor symptoms in perimenopausal women with overweight and obesity. The main questions it aims to answer are: 1.
- Obesity / overweightHeart / cardiovascular disease
π University of Alabama at Birmingham Β· Birmingham, AL Β· Get directions β
Natriuretic Peptides (NP) are hormones produced by the heart, and they have a wide range of favorable metabolic benefits. Lower levels of these hormones are associated with an increased likelihood of the development of diabetes and poor cardiometabolic health.
- Obesity / overweightType 2 diabetesHeart / cardiovascular disease
π Texas Diabetes Institute/UH Β· San Antonio, TX Β· Get directions β
Our goal of the study is to learn the effects of the diabetes medication named Pioglitazone, in type-2 diabetic obese participants with Heart failure. The main question it aims to answer are: 1.
- Obesity / overweightHeart / cardiovascular diseaseHigh blood pressure
π Miami-Dade County Parks, Recreation and Open Spaces Department Β· Miami, FL Β· Get directions β
The Active Older Adults prospective cohort study examines the effects of a park-based fitness program on cardiovascular fitness outcomes for older adults (aged 50 years and older). Duke will perform a secondary analysis of the data collected as part of the Active Older Adults prospective cohort study run by Miami-Dade County Parks and Recreation.
- Obesity / overweightHeart / cardiovascular diseaseHigh blood pressure
π University of Alabama at Birmingham Β· Birmingham, AL Β· Get directions β
Poor heart health puts Black women at risk for a shorter life with more illness than people of any other non-indigenous racial group. We will refine and conduct a randomized, wait-list controlled trial of Inspire HER (a heart health lifestyle intervention for Black women that provides health education, physical activity, and social resources).
- Obesity / overweightHeart / cardiovascular disease
New Heart Imaging Techniques to Evaluate Possible Heart Disease
π΅ May compensateπ National Institutes of Health Clinical Center Β· Bethesda, MD Β· Get directions β
Background: \- Imaging tests, such as magnetic resonance imaging (MRI), can provide information about heart and blood vessels. The tests let doctors can see the amount of blood vessel narrowing and vessel wall thickness.
- Obesity / overweightHeart / cardiovascular disease
π UVA Student Health and Wellness Building Β· Charlottesville, VA Β· Get directions β
The purpose of the study is to determine associations between fitness status, bacteria in the mouth, and the blood flow to muscle. This study is trying to find out if fitness status impacts the bacteria that are present in the oral microbiome (environment in the mouth) or the ability of the body to send blood to the skeletal muscle.
- Obesity / overweightHeart / cardiovascular disease
π Washington University in St. Louis Β· St Louis, MO Β· Get directions β
The focus on this application is low-income, rural patients, since cardiovascular disease (CVD) prevalence is 40% higher among rural than urban residents. Health behavior counseling and follow-up care are required for patients with an elevated body mass index who have increased risk for CVD.
- Obesity / overweightHeart / cardiovascular disease
π Washington University in St. Louis Β· St Louis, MO Β· Get directions β
This project will conduct a pilot hybrid study that examines the implementation (Aims 1 \& 2) and preliminary effectiveness (Aim 3) of PREVENT, a digital health intervention, among patients with overweight/obesity (N=100) using a clinic-randomized design. The central hypothesis of the study is that PREVENT will be feasible and show improvements in health behavior counseling and the patient experience that will improve patients' motivation to change, and their CVH health behaviors and outcomes.
- Heart / cardiovascular diseaseHigh blood pressure
π University of Kansas Medical Center Β· Kansas City, KS Β· Get directions β
The main purpose of research is to examine and understanding the development of hypertension in obese adults with insulin resistance. Findings from our studies will identify unique mechanisms that can be targeted to limit increases in vascular dysfunction and reduce the excessively high prevalence of hypertension and risk for cardiovascular disease (CVD).
- Obesity / overweightHeart / cardiovascular disease
π New Balance Foundation Obesity Prevention Center Β· Boston, MA Β· Get directions β
This study will evaluate the effects of whole vs. nonfat milk consumption on body composition, cardiometabolic disease risk factors, and dietary quality.
- Obesity / overweightHeart / cardiovascular diseaseHigh blood pressure
π University of Alabama at Birmingham Β· Birmingham, AL Β· Get directions β
Obese individuals have a higher prevalence of nocturnal hypertension and non-dipping blood pressure (BP). These conditions are associated with an increased risk of cardiovascular (CV) events and death.
- Obesity / overweightHeart / cardiovascular disease
π University of Texas Health Science Center at San Antonio Β· San Antonio, TX Β· Get directions β
Obesity and type 2 diabetes mellitus (T2DM) represent major public health concerns in the aging community. Tirzepatide, a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist recently approved for the treatment of T2DM and obesity has been shown to be effective at reducing weight, improving markers of T2DM control, and improving cardiovascular health.
- Obesity / overweightFatty liver disease (NASH/MASH)Heart / cardiovascular disease
π University of Missouri-Columbia Β· Columbia, MO Β· Get directions β
The purpose of this research study is to validate (check the accuracy of) laboratory assays, intravenous catheter insertion, and equipment or devices and their reproducibility, which is necessary to perform high quality research on chronic diseases, nutrition, and metabolism (the process by which a substance is handled in the body) at the University of Missouri. As technology changes and uses new testing methods, it is necessary to compare results from old tests, equipment and devices and new tests, equipment, or devices and the reproducibility of these measurements to make sure the results are accurate.
- Heart / cardiovascular diseaseHigh blood pressureCOPD (chronic lung disease)
π University of British Columbia Β· Kelowna, British Columbia Β· Get directions β
Chronic obstructive pulmonary disease (COPD) is a disease of the lungs that makes it hard for people to breath. Those with COPD spend considerably more time sitting and lying and less time performing physical activity than healthy individuals.
β Study care freeLearn more β - Obesity / overweightHeart / cardiovascular disease
π Brooklyn Clinical Research Β· Brooklyn, NY Β· Get directions β
SWIFT-CORE-101 is a single site survey study designed to assess potential participants' eligibility to screen for industry-sponsored clinical trials. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical history, comorbidities, and current symptoms.
- Obesity / overweightType 2 diabetesHeart / cardiovascular disease
π The Ohio State University Β· Columbus, OH Β· Get directions β
Lower attainment of cardiovascular health (CVH), indicated by the American Heart Association's Life's Simple 7 (LS7; physical activity, diet, cholesterol, blood pressure, body mass index, smoking, glycemia) and Life's Essential 8 (LE8; LS7+sleep) metrics, is a major contributor to Black men having the shortest life-expectancy of any non-indigenous race/sex group. Unfortunately, a paucity of literature exists on interventions aimed at improving CVH among Black men.
- Type 2 diabetesHeart / cardiovascular disease
π University of Texas Southwestern Medical Center Β· Dallas, TX Β· Get directions β
A pragmatic, randomized clinical trial to evaluate the effect of a heart failure (HF) risk assessment and prevention strategy incorporating HF clinical risk scores (WATCH-DM) with cardiac biomarker (NT-proBNP) paired with a clinical decision support tool to implement an intensive prevention strategy among patients with high risk focused on implementation of evidence-based HF preventive therapies.
β Study care freeLearn more β - Obesity / overweightType 2 diabetesHeart / cardiovascular disease
π West Virginia School of Osteopathic Medicine Β· Lewisburg, WV Β· Get directions β
Developed nations worldwide are currently enduring a health crisis, as chronic diseases continue to decrease quality of life and promote additional disease states or even death for much of the population. Rural populations are at a particular disadvantage, as they lack access to health clubs, wellness programs and similar resources that are more available in urban areas.
- Obesity / overweightHeart / cardiovascular disease
π University of Kentucky Β· Lexington, KY Β· Get directions β
The goal of this clinical trial is to learn if the drug semaglutide changes markers of disease risk as it relates to weight in children ages 12-15 years old who are obese (class 2 or 3). The main questions it aims to answer are: * How do the rate of weight loss, body mass index (BMI), body composition, heart structure and function, and exercise ability interact with one another in the study population at enrollment?
- Showing the first 60 of 95. Add filters or a location to narrow down.